BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Das BS, Das NC, Swain SS, Mukherjee S, Bhattacharya D. Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study. Future Virology. [DOI: 10.2217/fvl-2021-0171] [Reference Citation Analysis]
2 Frumkin LR, Lucas M, Scribner CL, Ortega-Heinly N, Rogers J, Yin G, Hallam TJ, Yam A, Bedard K, Begley R, Cohen CA, Badger CV, Abbasi SA, Dye JM, McMillan B, Wallach M, Bricker TL, Joshi A, Boon ACM, Pokhrel S, Kraemer BR, Lee L, Kargotich S, Agochiya M, John TS, Mochly-Rosen D. Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19. Front Immunol 2022;13:899617. [PMID: 35720389 DOI: 10.3389/fimmu.2022.899617] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ricardo S, Canão P, Martins D, Magalhães AC, Pereira M, Ribeiro-Junior U, de Mello ES, Alves VA, Pinto R, Leitão D, Alves G, Oliveira R, Wilton J, Costelha S, Meireles D, Cabanes D, David L, Schmitt F. Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression. Cancers (Basel) 2022;14:2582. [PMID: 35681562 DOI: 10.3390/cancers14112582] [Reference Citation Analysis]
4 Kumar A, Ladha A, Choudhury A, Ikbal AMA, Bhattacharjee B, Das T, Gupta G, Sharma C, Sarbajna A, Mandal SC, Choudhury MD, Ali N, Slama P, Rezaei N, Palit P, Tiwari ON. The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19? Expert Rev Vaccines 2022. [PMID: 35604776 DOI: 10.1080/14760584.2022.2081156] [Reference Citation Analysis]
5 Xi J, Lei LR, Zouzas W, April Si X. Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges. MedComm (2020) 2021;2:569-86. [PMID: 34977869 DOI: 10.1002/mco2.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Llivisaca-Contreras SA, Naranjo-Morán J, Pino-Acosta A, Pieters L, Vanden Berghe W, Manzano P, Vargas-Pérez J, León-Tamariz F, Cevallos-Cevallos JM. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2. Molecules 2021;26:4099. [PMID: 34279439 DOI: 10.3390/molecules26134099] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
7 Vianello A, Del Turco S, Babboni S, Silvestrini B, Ragusa R, Caselli C, Melani L, Fanucci L, Basta G. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? Biomedicines 2021;9:710. [PMID: 34201505 DOI: 10.3390/biomedicines9070710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Umashankar V, Deshpande SH, Hegde HV, Singh I, Chattopadhyay D. Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative in-silico Approach. Front Med (Lausanne) 2021;8:672629. [PMID: 34026798 DOI: 10.3389/fmed.2021.672629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
9 Huang ST, Chen Y, Chang WC, Chen HF, Lai HC, Lin YC, Wang WJ, Wang YC, Yang CS, Wang SC, Hung MC. Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Viruses 2021;13:826. [PMID: 34063247 DOI: 10.3390/v13050826] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
10 Pourriyahi H, Saghazadeh A, Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. J Neuroimmunol 2021;356:577578. [PMID: 33933818 DOI: 10.1016/j.jneuroim.2021.577578] [Reference Citation Analysis]
11 Palit P, Mukhopadhyay A, Chattopadhyay D. Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property. Phytother Res 2021;35:4246-57. [PMID: 33817867 DOI: 10.1002/ptr.7084] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Sarkar I, Sen G, Bhattacharya M, Bhattacharyya S, Sen A. In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration. J Biomol Struct Dyn 2021;:1-10. [PMID: 33810774 DOI: 10.1080/07391102.2021.1905556] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet 2021;304:5-38. [PMID: 33797605 DOI: 10.1007/s00404-021-06049-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
14 Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Mater 2021;:1-20. [PMID: 33718777 DOI: 10.1007/s42247-021-00192-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]